|
Volumn 85, Issue 2, 2016, Pages 231-232
|
Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis
|
Author keywords
Babesia microti; Babesiosis; Rituximab
|
Indexed keywords
ATOVAQUONE;
ATOVAQUONE PLUS PROGUANIL;
AZITHROMYCIN;
BABESIA MICROTI ANTIBODY;
CLINDAMYCIN;
ETANERCEPT;
PARASITE ANTIBODY;
RITUXIMAB;
UNCLASSIFIED DRUG;
ANTIRHEUMATIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
ANAMNESIS;
ARTICLE;
BABESIA MICROTI;
CASE REPORT;
DISEASE DURATION;
DNA DETERMINATION;
FEMALE;
HUMAN;
NONHUMAN;
PARASITE CLEARANCE;
PARASITE IDENTIFICATION;
PERSISTENT INFECTION;
PIROPLASMOSIS;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
ARTHRITIS, RHEUMATOID;
BABESIOSIS;
COMPLICATION;
ISOLATION AND PURIFICATION;
MIDDLE AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BABESIA MICROTI;
BABESIOSIS;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MIDDLE AGED;
RITUXIMAB;
|
EID: 84962264392
PISSN: 07328893
EISSN: 18790070
Source Type: Journal
DOI: 10.1016/j.diagmicrobio.2016.02.016 Document Type: Article |
Times cited : (43)
|
References (5)
|